T2C2

T2C2 Capital is a Montreal-based venture capital firm that specializes in early-stage and seed-round investments within the life sciences, healthcare, and information technology sectors. Founded in 1997 as T2C2/Bio-M, the firm was established to bridge the gap between academic research and commercialization by providing critical seed funding to startups emerging from universities and research centers. The acronym T2C2 stands for Transfer, state-of-the-art Technologies, optimal Commercialization, and interactive Capital. Over its history, the firm has managed multiple funds, including T2C2/Bio and T2C2/Bio 2000, and has been a key player in the Quebec biotechnology ecosystem, supporting companies like Enobia Pharma and Cytochroma.